Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dubai, UAE, March 29, 2026 (GLOBE NEWSWIRE) -- Pepeto is approaching the Binance listing, and the intensity building around this project mirrors what surrounded Dogecoin before it created...
-
Dubai, UAE, March 29, 2026 (GLOBE NEWSWIRE) -- Pepeto rolled out a major security upgrade on its DeFi exchange this week, and the presale responded by pushing past $8.49 million at a pace that tells...
-
New York City, March 29, 2026 (GLOBE NEWSWIRE) -- The newly formed firm and group are announcing their intention to raise initial bridge financing through offerings under the U.S. SEC’s Regulation D...
-
Fabhalta lowered likelihood of progression to kidney failure by 43% in APPLAUSE-IgAN study140.7% of patients on Fabhalta demonstrated sustained reduction of protein in urine over two years1Fabhalta...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto presale crossed $8.47 million after its latest presale round closed ahead of schedule, and the crypto news connecting this project to the BNB...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto pushed past $8.47 million after its latest round closed ahead of schedule while the crypto news today delivered the catalysts this bull run has...
-
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- The Pepeto team confirmed a major update to the exchange infrastructure as the presale pushes past $8.47 million with entries arriving faster every...
-
Gelatin trick 2026 warning: does the viral gelatin trick recipe work? Pink gelatin trick, ice gelatin trick, and Gelatine Sculpt examined.
-
2026 SteelPower performance report covers male enhancement formula details, ingredient research context, pricing, and guarantee disclosures.
-
In the Phase 2 part of the AMETHYST study, litifilimab met the primary endpoint of reduction of disease activity in people living with CLE at Week 16, with more litifilimab participants achieving...